Fibroblast growth factors: Potential novel targets for regenerative therapy of osteoarthritis

Tsung Ming Chen, Ya Huey Chen, Hsiao-Fang Sun, Shaw-Jenq Tsai

研究成果: Review article

1 引文 (Scopus)

摘要

Osteoarthritis (OA) is a degenerative joint disorder and is the leading cause of disability of people, which negatively impact people’s physical and mental health. Although OA causes great socioeconomic burden and individual suffering, no effective treatment options are provided so far. This is partially resulted from poor regenerative activity of articular cartilage and our incomplete understanding of the underlying mechanism of OA. Traditional drug therapies such as acetaminophen and opioids are effective in relieving pain but do not reverse cartilage damage and are often associated with adverse events. Therefore, it is necessary to find effective OA drugs. In recent years, novel regenerative therapies have received much attention because they can effectively promote tissue repair and regeneration. The fibroblast growth factor (FGF) signaling has been suggested to involve in cartilage homeostasis for decades. The current research shows that sprifermin/recombinant FGF18 significantly reduces the loss of cartilage thickness and volume without serious side effects, thus warrants a continued research for potential new medications of OA. This review mainly highlights the current research progress on FGFs and FGF receptors as a potential therapeutic target for OA.

原文English
頁(從 - 到)2-10
頁數9
期刊Chinese Journal of Physiology
62
發行號1
DOIs
出版狀態Published - 2019 一月 1

指紋

Fibroblast Growth Factors
Osteoarthritis
Cartilage
Therapeutics
Research
Fibroblast Growth Factor Receptors
Articular Cartilage
Acetaminophen
Psychological Stress
Opioid Analgesics
Regeneration
Mental Health
Homeostasis
Joints
Drug Therapy
Pain
Pharmaceutical Preparations

All Science Journal Classification (ASJC) codes

  • Physiology
  • Physiology (medical)

引用此文

@article{fbcfe2b6b221437a84f9211434f0a5e9,
title = "Fibroblast growth factors: Potential novel targets for regenerative therapy of osteoarthritis",
abstract = "Osteoarthritis (OA) is a degenerative joint disorder and is the leading cause of disability of people, which negatively impact people’s physical and mental health. Although OA causes great socioeconomic burden and individual suffering, no effective treatment options are provided so far. This is partially resulted from poor regenerative activity of articular cartilage and our incomplete understanding of the underlying mechanism of OA. Traditional drug therapies such as acetaminophen and opioids are effective in relieving pain but do not reverse cartilage damage and are often associated with adverse events. Therefore, it is necessary to find effective OA drugs. In recent years, novel regenerative therapies have received much attention because they can effectively promote tissue repair and regeneration. The fibroblast growth factor (FGF) signaling has been suggested to involve in cartilage homeostasis for decades. The current research shows that sprifermin/recombinant FGF18 significantly reduces the loss of cartilage thickness and volume without serious side effects, thus warrants a continued research for potential new medications of OA. This review mainly highlights the current research progress on FGFs and FGF receptors as a potential therapeutic target for OA.",
author = "Chen, {Tsung Ming} and Chen, {Ya Huey} and Hsiao-Fang Sun and Shaw-Jenq Tsai",
year = "2019",
month = "1",
day = "1",
doi = "10.4103/CJP.CJP_11_19",
language = "English",
volume = "62",
pages = "2--10",
journal = "Chinese Journal of Physiology",
issn = "0304-4920",
publisher = "Chinese Physiological Society",
number = "1",

}

Fibroblast growth factors : Potential novel targets for regenerative therapy of osteoarthritis. / Chen, Tsung Ming; Chen, Ya Huey; Sun, Hsiao-Fang; Tsai, Shaw-Jenq.

於: Chinese Journal of Physiology, 卷 62, 編號 1, 01.01.2019, p. 2-10.

研究成果: Review article

TY - JOUR

T1 - Fibroblast growth factors

T2 - Potential novel targets for regenerative therapy of osteoarthritis

AU - Chen, Tsung Ming

AU - Chen, Ya Huey

AU - Sun, Hsiao-Fang

AU - Tsai, Shaw-Jenq

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Osteoarthritis (OA) is a degenerative joint disorder and is the leading cause of disability of people, which negatively impact people’s physical and mental health. Although OA causes great socioeconomic burden and individual suffering, no effective treatment options are provided so far. This is partially resulted from poor regenerative activity of articular cartilage and our incomplete understanding of the underlying mechanism of OA. Traditional drug therapies such as acetaminophen and opioids are effective in relieving pain but do not reverse cartilage damage and are often associated with adverse events. Therefore, it is necessary to find effective OA drugs. In recent years, novel regenerative therapies have received much attention because they can effectively promote tissue repair and regeneration. The fibroblast growth factor (FGF) signaling has been suggested to involve in cartilage homeostasis for decades. The current research shows that sprifermin/recombinant FGF18 significantly reduces the loss of cartilage thickness and volume without serious side effects, thus warrants a continued research for potential new medications of OA. This review mainly highlights the current research progress on FGFs and FGF receptors as a potential therapeutic target for OA.

AB - Osteoarthritis (OA) is a degenerative joint disorder and is the leading cause of disability of people, which negatively impact people’s physical and mental health. Although OA causes great socioeconomic burden and individual suffering, no effective treatment options are provided so far. This is partially resulted from poor regenerative activity of articular cartilage and our incomplete understanding of the underlying mechanism of OA. Traditional drug therapies such as acetaminophen and opioids are effective in relieving pain but do not reverse cartilage damage and are often associated with adverse events. Therefore, it is necessary to find effective OA drugs. In recent years, novel regenerative therapies have received much attention because they can effectively promote tissue repair and regeneration. The fibroblast growth factor (FGF) signaling has been suggested to involve in cartilage homeostasis for decades. The current research shows that sprifermin/recombinant FGF18 significantly reduces the loss of cartilage thickness and volume without serious side effects, thus warrants a continued research for potential new medications of OA. This review mainly highlights the current research progress on FGFs and FGF receptors as a potential therapeutic target for OA.

UR - http://www.scopus.com/inward/record.url?scp=85064135158&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85064135158&partnerID=8YFLogxK

U2 - 10.4103/CJP.CJP_11_19

DO - 10.4103/CJP.CJP_11_19

M3 - Review article

C2 - 30942193

AN - SCOPUS:85064135158

VL - 62

SP - 2

EP - 10

JO - Chinese Journal of Physiology

JF - Chinese Journal of Physiology

SN - 0304-4920

IS - 1

ER -